The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients

• Váldodahkkit: Melissa A. Jackson (Dahkki), Amanda L. Brown (Dahkki), Jennifer Johnston (Dahkki), Richard Clancy (Dahkki), Iain McGregor (Dahkki), Raimondo Bruno (Dahkki), Nick Lintzeris (Dahkki), Mark Montebello (Dahkki), Jennifer Luksza (Dahkki), Jenny Bowman (Dahkki), Nghi Phung (Dahkki), Dave Allsop (Dahkki), Adrian J. Dunlop (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2021-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Introduction Despite decreasing consumption by general populations, use of synthetic cannabinoid receptor agonists (SCRAs) persists in some marginalised groups, including those who use other substances. This article explores SCRA consumption in an Australian cannabis treatment sample, compa...